Effects of a self-management program on antiemetic-induced constipation during chemotherapy among breast cancer patients: a randomized controlled clinical trial

Research on patient-reported outcomes indicates that constipation is a common adverse effect of chemotherapy, and the use of 5-hydroxytryptamine (serotonin; 5HT(3)) receptor antagonists aggravates this condition. As cancer patients take multiple drugs as a part of their clinical management, a non-ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanai, Akiko, Ishiguro, Hiroshi, Sozu, Takashi, Tsuda, Moe, Arai, Hidenori, Mitani, Akira, Tsuboyama, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705125/
https://www.ncbi.nlm.nih.gov/pubmed/26650825
http://dx.doi.org/10.1007/s10549-015-3652-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705125/
https://www.ncbi.nlm.nih.gov/pubmed/26650825
http://dx.doi.org/10.1007/s10549-015-3652-4

Ejemplares similares